Arrakis in the News

September 29, 2020
Timmerman Report

May 5, 2020

April 8, 2020
RNA-targeting small molecule play Arrakis taps Roche as first pharma partner

April 8, 2020
Arrakis, Roche team up on RNA-targeting drugs in $190M deal

April 8, 2020
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

April 8, 2020
BioPharma Dive
Amid a pandemic, Roche bets $190M on Arrakis and drugging RNA

April 18, 2019
STAT – The Readout Loud biotech podcast
Drugging the undruggable

Biotech entrepreneur Michael Gilman dials in to talk about his company’s efforts to craft pills that can do what has thus far proved impossible.

October 2, 2018
FierceBiotech’s 2018 Fierce 15: Arrakis – Mining the RNA world for new medicines

January 10, 2018
Endpoints News
The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds

November 28, 2017
Nature Reviews Drug Discovery
Small molecules against RNA targets attract big backers

November 6, 2017
C&EN (Chemical & Engineering News)
Arrakis is selected as one of C&EN’s Ten Start-Ups to Watch: “Meet the master builders behind chemistry’s most intriguing young companies.”
Ten Start-Ups to Watch

August 8, 2017
Arrakis is selected as a finalist for the Xconomy Awards as Big Idea of the year. Winners will be announced on September 26.
Xconomy Award Finalists

March 2, 2017
BioCentury Innovations
RNA, Meet Small Molecules

February 28, 2017
BioWorld Today
Gilman-led Arrakis Lands $38M Series A Round

February 27, 2017
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills

February 27, 2017
Endpoints News
Going Big: Biotech Vets Blast off with Arrakis on a New Journey of RNA Exploration

February 27, 2017
Fierce Biotech
Pfizer, Celgene-Backed Upstart Arrakis Hopes to Mine RNA Spice

Back to Top